[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 49 (22) , 1583-1591
- https://doi.org/10.1016/0024-3205(91)90052-d
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in ratsLife Sciences, 1991
- Parallelin Vivoandin VitroDetection of Functional Somatostatin Receptors in Human Endocrine Pancreatic Tumors: Consequences with Regard to Diagnosis, Localization, and TherapyJournal of Clinical Endocrinology & Metabolism, 1990
- Long-term culture of rat mammotrope and somatotrope subpopulations separated on continuous Percoll density gradients: Effects of dopamine, TRH, GHRH and somatostatinActa Endocrinologica, 1990
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Hormone-Producing Gastrointestinal Tumors Contain a High Density of Somatostatin ReceptorsJournal of Clinical Endocrinology & Metabolism, 1987
- New specific radioligand for one subpopulation of brain somatostatin receptorsLife Sciences, 1985
- Growth Hormone Secretion by Cultured Rat Anterior Pituitary Cells. Effects of Culture Conditions and Dexamethasone*Endocrinology, 1983
- Radioactive Labeling of Antibody: A Simple and Efficient MethodScience, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- High affinity binding sites for a somatostatin-28 analog in rat brainLife Sciences, 1981